INFLAMMATORY BOWEL DISEASES
Keywords:
A distinctive feature of CD is transmural segmental granulomatous inflammation, which can be localized in all parts of the gastrointestinal tract – from the mouth to the anus. In UC, the lesion classically affects only the colon and rectum and the inflammatory process is limited to the mucous membrane and has a diffuse character.Abstract
Inflammatory bowel diseases (IBD) combine two chronic recurrent inflammatory diseases – Crohn's disease (CD) and ulcerative colitis (UC). IBD is an immuno-mediated disease of unknown etiology and is a chronic inflammatory process affecting the large intestine in the case of UC and various parts of the gastrointestinal tract (GI tract) in the case of CD. Typical symptoms of IBD are abdominal pain, diarrhea (often with an admixture of blood), fever, weight loss, and less often extra-intestinal symptoms (lesions of joints, eyes, and skin) may occur.
Downloads
References
Crohn's disease. Clinical recommendation MH RF. 2020. P. 52.
Nonspecific ulcerative colitis. Clinical recommendation MH RF. 2020. P. 57.
Akhrieva Kh.M., Tertychny A.S., Mayev I.V. et al. Classification and morphological diagnosis of ulcerative colitis and Crohn's disease. Clinical and experimental morphology. 2017;3(23):4-16. (In Russ).
Bakulin I.G., Skalinskaya M.I., Skazyvaeva E.V. The place of mesalazine in the treatment of ulcerative colitis. Medical council. 2017;15. (In Russ).
Belousova E.A., Nikitina N.V., Tsodikova O.M. Treatment of ulcerative colitis of light and moderate severity. Pharmateca. 2013;2:42-46. (In Russ).
Grigorieva G.A., Meshalkina N.Yu. Crohn's disease. Moscow, 2007. 184 p. (In Russ).
Livzan M.A., Makeikina M.A. Inflammatory diseases of the intestine: modern aspects of diagnosis and treatment. Gastroenterology. 2012;2. (In Russ).
Sukhina M.A., Obraztsov I.V., Mikhalevskaya V.I. et al. Algorithm for laboratory diagnosis of clostridium difficile-associated diarrhea. Journal of Microbiology, Epidemiology, and Immunobiology (ZHMEI). 2018;2:45- 53. (In Russ).
Carter MJ, Lobo AJ, Travis SP; IBD Section, British Society of Gastroenterology. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2004;53:1-16.
Parente F, Greco S, Molteni M et al. Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical location within the bowel. Alimentary Pharmacology and Therapeutics. 2003;18:1009-1016.
Ford AC, Achkar J-P, Khan KJ, Kane SV, Talley NJ, et al. Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis. Am J Gastroenterol. 2011;106:601-616.
D"Haens G et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology. 2007;132:763-786.
Chen JH, Andrews JM, Kariyawasam V, Moran N. IBD Sydney Organisation and the Australian Inflammatory Bowel Diseases Consensus Working Group. Review article: acute severe ulcerative colitis - evidence-based consensus statements. Aliment Pharmacol Ther. 2016 Jul; 44(2):127-144.
